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The mechanism by which mechanosignal transduction regulates stem cell fate is not well understood. In this
issue of Developmental Cell, Tang et al. (2013) demonstrate that catalytic function of the metalloproteinase
MT1-MMP controls ECM structure, cell shape, and an integrin/Rho/YAP-TAZ signaling axis to control
osteogenic stem cell fate.Skeletal stem cells (SSCs), also known
as mesenchymal stem cells, are progen-
itors of bone, fat, and cartilage. As such,
they are professional creators and reor-
ganizers of extracellular matrix (ECM)
and reside in a bone-associated niche
rich in collagen I. In vitro, SSCs respond
to the stiffness and topology of their
environment such that cell fate toward
osteogenesis is promoted by stiffer sur-
faces (Engler et al., 2006; Huebsch
et al., 2010). These results clearly estab-
lish a mechanosignaling response in
SSCs. However, a more complex ques-
tion remains: how do SSCs, adept at
depositing and remodeling the ECM,
respond to the dynamic microenviron-
ment in which they reside and that they
regulate? What feedback mechanisms
are at play, and what molecules are
involved? In this issue of Developmental
Cell, Tang et al. (2013) identify a key
piece to this puzzle by investigating the
role of ECM remodeling in the determina-
tion of SSC fate in the complex in vivo
environment.
One of the ways cells remodel the ECM
is through the action of proteases such
as metalloproteinases and cathepsins.
There are more than 20 members in the
matrix metalloproteinase family (MMP)
alone. Of these, MT1-MMP (MMP14) has
emerged as a key member. MT1-MMP is
a transmembrane protease that is ubiqui-
tous in distribution and is required for
normal embryonic development (Zhou
et al., 2000). Now, Tang et al. (2013)
demonstrate that the MT1-MMP is also a
key regulator of SSC fate.
Because deletion of MT1-MMP is
embryonic lethal, the authors created a
conditional knockout mouse to specif-ically delete MT1-MMP in the mesen-
chymal progenitors and SSCs. These
mice display profound defects in the
formation of bone, characterized by
osteopenia and an increase in articular
cartilage and bone-marrow adipose cells.
Because these lineages all arise from
a common precursor, these results sug-
gest an effect on the SSCs.
Interestingly, using isolated SSCs,
Tang et al. (2013) found that MT1-MMP
loss had no effect on the formation of
osteoblasts in standard 2D cell culture.
However, when SSCs were cultured in
3D collagen gels, cells lacking MT1-
MMP significantly decreased osteoblast
commitment, with a corresponding in-
crease in the adipocyte lineage. More-
over, when cells were cultured on top of
3D collagen gels of matching composition
and stiffness, this regulation of SSC fate
was lost, and osteoblasts were again
formed, regardless of MT1-MMP levels.
Thus, it is the presence of ECM surround-
ing the cells that is key to whether MT1-
MMP loss manifests a phenotype. This
finding has important implications for all
in vitro studies using 2D surfaces, even
those in which the stiffness has been
altered, and indicates the importance of
confirming results in 3D matrices that
more closely mimic the in vivo niche.
Protease activity of MT1-MMP is
crucial, as reexpression of catalytically
inactive MT1-MMP phenocopied loss
of the enzyme. Without MT1-MMP activ-
ity, the authors observed a loss of
collagen remodeling, resulting in exces-
sive deposition of large bundles of
collagen fibers in bone. This confirms a
host of past studies suggesting that it is
the remodeling activity of the osteogenicDevelopmental Cellineage, not collagen deposition per se,
that is necessary for the formation of
functional bone.
Loss of MT1-MMP activity results in
a loss of b1 integrin activation and a
corresponding loss of FAK phos-
phorylation. When b1 integrin is artifi-
cially activated using clustering mutants,
FAK phosphorylation is restored, as is
the ability of the cells to pursue the
osteogenic lineage and suppress the
adipogenic lineage. The pathway for
osteogenic fate specification requires
activation of Rho and cell-derived trac-
tion forces against the ECM. This
describes an important and hitherto
unknown role for mechanosignaling
through b1 integrin and FAK not only in
determining the osteogenic lineage, but
also in restricting the chondrogenic and
adipogenic lineages.
The mechanical responsiveness of
SSCs suggested that YAP/TAZ transcrip-
tional regulators, which have recently
emerged as important regulators of
mesenchymal stem cells in response to
mechanical signals (Dupont et al., 2011;
Zhong et al., 2013), might be involved.
Tang et al. (2013) thus expanded upon
this work, finding that YAP and its coacti-
vator TAZ localize to cell nuclei in 3D
culture and in vivo only when MT1-MMP
is functional and the b1 integrin/FAK
pathway is activated. Further studies are
needed to identify the full complement of
genes regulated by YAP/TAZ in SSCs
downstream of the MT1-MMP pathway
and their regulation under different 3D
matrix stiffness conditions. Candidate
genes that could determine osteogenic
fate include transcriptional coactivation of
RNX2 osteogenic factors and repressionl 25, May 28, 2013 ª2013 Elsevier Inc. 325
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Previewsof PPARg adipogenic factors. Because
TAZ interacts with both RNX2 and
PPARg, a lingering question is how this
interaction is preferentially regulated by
matrix stiffness and organization.
The model that emerges from the work
of Tang et al. (2013) suggests that it is
cell shape that ultimately regulates fate.
When cells can round up, they move into
chondrogenic and adipogenic lineages.
Conversely, when cells can remodel the
ECM, including the deposition of new
components, they are able to elongate
via Rho-driven cellular tension, allowing
them to activate b1 integrins, activate
FAK, and regulate gene expression via
YAP/TAZ. An intriguing finding here is
that MT1-MMP proteolysis is necessary
for cell elongation under these conditions,
and it is likely related to the ability of the
cells to deposit and remodel the ECM.
An important lingering question is whether
the bundling of collagen into thickened
fibers when MT1-MMP is lost controls
SSC fate. There is probably more at play
than we currently understand, and it will
be fascinating to see what is uncovered
in future studies.
As additional work probes this
pathway, it will be of interest to determine
whether other substrates of MT1-MMP
activity are involved in regulating osteo-
genic commitment. MT1-MMP cleaves326 Developmental Cell 25, May 28, 2013 ª2other ECM proteins and cell-surface
receptors and releases latent growth
factors from the ECM. However, in this
story, the important finding that loss
of MT1-MMP regulates SSC fate in the
presence of a cleavable 3D collagen
matrix, and not in 2D culture, suggests
that effects are probably attributable to
cleavage of collagen rather than other
substrates (although it remains possible
that 3D culture regulates surface expres-
sion of proteins whose cleavage is key
to fate specification).
The implications of this work likely
reach far beyond SSC fate, as ECM stiff-
ness is emerging as a regulator of multiple
cell lineages and MT1-MMP is ubiquitous
and necessary for development of the
embryo. It will be interesting to discover
whether this mechanism is at play in other
tissues and for other adult stem cells or,
more broadly, at the earliest stages of
embryonic stem cell fate determination.
Moreover, is this mechanism a key
regulator of cancer stem cells or the
tumor microenvironment? Recent the-
ories postulate that tumor-associated
fibroblasts are derived from the influx of
circulating mesenchymal stem cells to
the site of the tumor (Karnoub et al.,
2007; Mishra et al., 2008), where they
deposit an extracellular matrix distinct
from the resident fibroblasts. Future013 Elsevier Inc.studies may determine whether a similar
MT1-MMP/b1 integrin/YAP-TAZ signaling
axis helps to drive the fate of these cells
in the tumor microenvironment.REFERENCES
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Genomes for three species of turtles were recently reported in Nature Genetics and Genome Biology.
The findings of Wang et al. (2013) and Abramyan et al. (2013) place the turtles as a sister group to birds
and crocodiles and offer clues to the origins of this group’s remarkable physiological traits.Turtles are bones of contention. Their
body plan is unique, appears abruptly in
the fossil record, and has resisted at-
tempts to form a consensus as to which
group of organisms gave rise to turtles.
Rather, there are three extant phylog-enies, each modeling a different origin of
Testudines (Lyson et al., 2012). Most
morphologists tend to favor separating
turtles from the crown group of Reptilia,
putting them into a distinct and otherwise
wholly extinct parareptilian group onthe basis of the turtles’ characteristic
anapsid skull anatomy. Molecular biolo-
gists, however, tend to view turtles as
normal reptiles whose nuclear and
mitochondrial genes demonstrate their
affinities to Archosauria (birds and
